{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:35:23Z","timestamp":1782398123707,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Immunoglobulin (Ig) G4-related disease (IgG4-RD) is a systemic disorder involving benign mass formation due to fibrosis and intense lymphoplasmacytosis; the chronic inflammation associated with the disease might also contribute to oncogenesis. Activation-induced cytidine deaminase (AID), normally expressed in germinal centre activated B-cells, is an enzyme that edits DNA\/RNA and induces somatic hypermutation and Ig class switching. AID expression is strictly controlled under physiological conditions; however, chronic inflammation and some infectious agents induce its up-regulation. AID is overexpressed in various cancers and may be important in chronic inflammation-associated oncogenesis. We examined AID expression in IgG4-related sialadenitis (n\u2009=\u200914), sialolithiasis (non-specific inflammation, n\u2009=\u200913), and normal submandibular glands (n\u2009=\u200913) using immunohistochemistry and quantitative real-time polymerase chain reaction (qPCR). Immunohistochemistry revealed significantly more AID-expressing cells in IgG4-related sialadenitis than in sialolithiasis or normal submandibular gland samples (<jats:italic>P<\/jats:italic>\u2009=\u20090.02 and <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01, respectively); qPCR yielded similar results. Thus, AID was significantly more up-regulated and had higher expression in extra-germinal centres in IgG4-RD than in non-specific inflammation or normal conditions. This report suggests that IgG4-RD has several specific causes of AID up-regulation in addition to inflammation. Furthermore, chronic inflammation-associated AID-mediated oncogenesis is possible in IgG4-RD.<\/jats:p>","DOI":"10.1038\/s41598-018-37404-x","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T11:04:17Z","timestamp":1548327857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Up-regulation of activation-induced cytidine deaminase and its strong expression in extra-germinal centres in IgG4-related disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Yuka","family":"Gion","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Miyata-Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorihisa","family":"Orita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyasu","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuharu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"37404_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/s10165-011-0508-6","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara, H. et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 22, 1\u201314 (2012).","journal-title":"Mod Rheumatol."},{"key":"37404_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3960\/jslrt.51.13","volume":"51","author":"Y Masaki","year":"2011","unstructured":"Masaki, Y., Kurose, N. & Umehara, H. IgG4-related disease: a novel lymphoproliferative disorder discovered and established in Japan in the 21st century. J Clin Exp Hematop. 51, 13\u201320 (2011).","journal-title":"J Clin Exp Hematop."},{"key":"37404_CR3","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/hep.21697","volume":"45","author":"Y Zen","year":"2007","unstructured":"Zen, Y. et al. Th2 and regulatory immune reactions are increased in immunoglobulin G4-related sclerosing pancreatitis and cholangitis. Hepatology. 45, 1538\u20131546 (2007).","journal-title":"Hepatology."},{"key":"37404_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3109\/s10165-011-0520-x","volume":"22","author":"M Yamamoto","year":"2012","unstructured":"Yamamoto, M. et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 22, 414\u2013418 (2012).","journal-title":"Mod Rheumatol."},{"key":"37404_CR5","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3899\/jrheum.150436","volume":"42","author":"J Asano","year":"2015","unstructured":"Asano, J. et al. Association between immunoglobulin G4-related disease and malignancy within 12 years after diagnosis: an analysis after longterm followup. J Rheumatol. 42, 2135\u20132142 (2015).","journal-title":"J Rheumatol."},{"key":"37404_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1440-1827.2008.02257.x","volume":"58","author":"Y Sato","year":"2008","unstructured":"Sato, Y. et al. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int. 58, 465\u2013470 (2008).","journal-title":"Pathol Int."},{"key":"37404_CR7","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/PAS.0b013e31816148ad","volume":"32","author":"W Cheuk","year":"2008","unstructured":"Cheuk, W. et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 32, 1159\u20131167 (2008).","journal-title":"Am J Surg Pathol."},{"key":"37404_CR8","doi-asserted-by":"publisher","first-page":"18470","DOI":"10.1074\/jbc.274.26.18470","volume":"274","author":"M Muramatsu","year":"1999","unstructured":"Muramatsu, M. et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B-cells. J Biol Chem. 274, 18470\u201318476 (1999).","journal-title":"J Biol Chem."},{"key":"37404_CR9","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1158\/0008-5472.CAN-14-3028","volume":"75","author":"Y Sawai","year":"2015","unstructured":"Sawai, Y. et al. Activation-induced cytidine deaminase contributes to pancreatic tumorigenesis by inducing tumor-related gene mutations. Cancer Res. 75, 3292\u20133301 (2015).","journal-title":"Cancer Res."},{"key":"37404_CR10","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1038\/onc.2011.352","volume":"31","author":"A Takai","year":"2012","unstructured":"Takai, A. et al. Targeting activation-induced cytidine deaminase prevents colon cancer development despite colonic inflammation. Oncogene. 31, 1733\u20131742 (2012).","journal-title":"Oncogene."},{"key":"37404_CR11","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.1038\/sj.onc.1210344","volume":"26","author":"Y Endo","year":"2007","unstructured":"Endo, Y. et al. Expression of activation-induced cytidine deaminase in human hepatocytes via NF-\u03baB signaling. Oncogene. 26, 5587\u20135595 (2007).","journal-title":"Oncogene."},{"key":"37404_CR12","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1053\/j.gastro.2012.07.009","volume":"143","author":"T Chiba","year":"2012","unstructured":"Chiba, T., Marusawa, H. & Ushijima, T. Inflammation-assiciated cancer development in digestive organs: Mechanisms and roles of for genetic and epigenetic modulations. Gastroenterology. 143, 550\u2013563 (2012).","journal-title":"Gastroenterology."},{"key":"37404_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2169\/internalmedicine.53.1342","volume":"53","author":"K Hirano","year":"2014","unstructured":"Hirano, K. et al. Incidence of malignancies in patients with IgG4-realated disease. Intern Med. 53, 171\u20130176 (2014).","journal-title":"Intern Med."},{"key":"37404_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/MPA.0000000000000053","volume":"43","author":"PA Hart","year":"2014","unstructured":"Hart, P. A. et al. Risk of cancer in autoimmune pancreatitis: a case-control study and review of the literature. Pancreas. 43, 417\u2013421 (2014).","journal-title":"Pancreas."},{"key":"37404_CR15","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/art.39773","volume":"68","author":"ZS Wallace","year":"2016","unstructured":"Wallace, Z. S., Wallace, C. J., Lu, N., Choi, H. K. & Stone, J. H. Association of IgG4-related disease with history of malignancy. Arthritis Rheumatol. 68, 2283\u20132289 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"37404_CR16","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1097\/MPA.0b013e3181b65a1c","volume":"38","author":"T Kamisawa","year":"2009","unstructured":"Kamisawa, T. et al. Frequent and significant K-ras mutation in the pancreas, the bile duct, and the gallbladder in autoimmune pancreatitis. Pancreas. 38, 890\u2013895 (2009).","journal-title":"Pancreas."},{"key":"37404_CR17","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00535-010-0211-y","volume":"45","author":"T Kamisawa","year":"2010","unstructured":"Kamisawa, T. et al. K-ras mutation in the major duodenal papilla and gastric and colonic mucosa in patients with autoimmune pancreatitis. J Gastroenterol. 45, 771\u2013778 (2010).","journal-title":"J Gastroenterol."},{"key":"37404_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep13539","volume":"5","author":"K Ohno","year":"2015","unstructured":"Ohno, K. et al. A subset of ocular adnexal marginal zone lymphomas may arise in association with IgG4-related disease. Sci Rep. 5, 13539 (2015).","journal-title":"Sci Rep."},{"key":"37404_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature05610","volume":"446","author":"C Greenman","year":"2007","unstructured":"Greenman, C. et al. Patterns of somatic mutation in human cancer genomes. Nature. 446, 153\u2013158 (2007).","journal-title":"Nature."},{"key":"37404_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev.immunol.20.090501.112049","volume":"20","author":"T Honjo","year":"2002","unstructured":"Honjo, T., Kinoshita, K. & Muramatu, M. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu Rev Immunol. 20, 165\u2013196 (2002).","journal-title":"Annu Rev Immunol."},{"key":"37404_CR21","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1182\/blood-2002-08-2424","volume":"101","author":"J Greeve","year":"2002","unstructured":"Greeve, J. et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood. 101, 3574\u20133580 (2002).","journal-title":"Blood."},{"key":"37404_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nri.2016.2","volume":"16","author":"R Casellas","year":"2016","unstructured":"Casellas, R. et al. Mutations, kataegis and translocations in B cells: understanding AID promiscuous activity. Nat Rev Immunol. 16, 164\u2013176 (2016).","journal-title":"Nat Rev Immunol."},{"key":"37404_CR23","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.cell.2008.09.062","volume":"135","author":"DF Robbiani","year":"2008","unstructured":"Robbiani, D. F. et al. AID is required for the chromosomal breaks in c-myc that lead to c-myc\/IgH translocations. Cell. 135, 1028\u20131038 (2008).","journal-title":"Cell."},{"key":"37404_CR24","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nm1566","volume":"13","author":"Y Matsumoto","year":"2007","unstructured":"Matsumoto, Y. et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med. 13, 470\u2013476 (2007).","journal-title":"Nat Med."},{"key":"37404_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/ijc.22292","volume":"120","author":"T Kou","year":"2007","unstructured":"Kou, T. et al. Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis. Int J Cancer. 120, 469\u2013476 (2007).","journal-title":"Int J Cancer."},{"key":"37404_CR26","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1084\/jem.20030275","volume":"197","author":"IM Okazaki","year":"2003","unstructured":"Okazaki, I. M. et al. Constitutive expression of AID leads to tumorigenesis. J Exp Med. 197, 1173\u20131181 (2003).","journal-title":"J Exp Med."},{"key":"37404_CR27","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1053\/j.gastro.2010.07.010","volume":"139","author":"Y Matsumoto","year":"2010","unstructured":"Matsumoto, Y. et al. Up-regulation of activation-induced cytidine deaminase causes genetic aberrations at the CDDKN2b-CDKN2a in gastric cancer. Gastroenterology. 139, 1984\u20131994 (2010).","journal-title":"Gastroenterology."},{"key":"37404_CR28","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1365-2249.2008.03651.x","volume":"152","author":"K Yamada","year":"2008","unstructured":"Yamada, K. et al. Clonal relationship between infiltrating immunoglobulin G4 (IgG4)-positive plasma cells in lacrimal glands and circulating IgG4-positive lymphocytes in Mikulicz\u2019s disease. Clin Exp Immunol. 152, 432\u2013439 (2008).","journal-title":"Clin Exp Immunol."},{"key":"37404_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3109\/08916934.2012.749244","volume":"46","author":"H Zan","year":"2013","unstructured":"Zan, H. & Casali, P. Regulation of Aicda expression and AID activity. Autoimmunity. 46, 83\u2013101 (2013).","journal-title":"Autoimmunity."},{"key":"37404_CR30","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1128\/JVI.73.6.4713-4720.1999","volume":"73","author":"H Marusawa","year":"1999","unstructured":"Marusawa, H., Hijikata, M., Chiba, T. & Shimotohno, K. Hepatitis C virus core protein inhibits Fas-and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol. 73, 4713\u20134720 (1999).","journal-title":"J Virol."},{"key":"37404_CR31","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.bbrc.2007.07.022","volume":"361","author":"RJ Kim","year":"2007","unstructured":"Kim, R. J. et al. IL-4-induced AID expression and its relevance to IgA class switch recombination. Biochem Biophys Res Commun. 361, 398\u2013403 (2007).","journal-title":"Biochem Biophys Res Commun."},{"key":"37404_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/ar3924","volume":"14","author":"H Tsuboi","year":"2012","unstructured":"Tsuboi, H. et al. Analysis of IgG4 class switch-related molecules in IgG4-related disease. Arthritis Res Ther. 14, 171 (2012).","journal-title":"Arthritis Res Ther."},{"key":"37404_CR33","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande, V. et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 25, 1181\u20131192 (2012).","journal-title":"Mod Pathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37404-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37404-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37404-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T05:10:12Z","timestamp":1671253812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37404-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["37404"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-37404-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]},"assertion":[{"value":"20 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"761"}}